Skip to main content
RaySearch Laboratories logo

RaySearch Laboratories — Investor Relations & Filings

Ticker · RAY ISIN · SE0000135485 LEI · 549300TYFVYGS0JFWM28 ST Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 590 across all filing types
Latest filing 2011-01-12 Board/Management Inform…
Country SE Sweden
Listing ST RAY

About RaySearch Laboratories

https://www.raysearchlabs.com/

RaySearch Laboratories develops advanced software solutions for radiation therapy and oncology. The company's product suite includes the RayStation® treatment planning system, the RayCare® oncology information system, and the RayIntelligence® oncology analytics system. These integrated platforms are engineered to enhance the efficiency, precision, and automation of cancer treatment workflows for clinics worldwide. By collaborating with leading cancer centers and research institutions, RaySearch aims to accelerate innovation in the field. The software is used by thousands of clinics to help clinicians plan and manage complex treatments, ultimately working to improve patient outcomes in the fight against cancer.

Recent filings

Filing Released Lang Actions
RaySearch establishes North American sales organization
Board/Management Information Classification · 95% confidence The document is a press release dated January 12, 2011, announcing the establishment of a US subsidiary, RaySearch Americas Inc., to market the RayStation® treatment planning system in North America. This announcement details strategic business expansion, recruitment of key personnel (President/CEO and VP of Sales), and provides background information on the company and its product. This type of announcement, concerning strategic business changes and executive appointments, most closely aligns with the 'Board/Management Information' (MANG) category, as it involves establishing a new operational entity and appointing leadership, which is a significant management decision. It is not a formal regulatory filing like a 10-K, an earnings release, or a dividend notice. Given the focus on establishing a new sales organization and appointing its leadership, MANG is the most appropriate fit.
2011-01-12 English
Interim / Quarterly Report 2010
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for RaySearch Laboratories AB covering the period from January 1 to September 30, 2010. It contains comprehensive financial statements, management commentary, and operational updates for the nine-month period. It is not an announcement of a report, but the report itself, containing substantive financial data and analysis. 9M 2010
2010-11-12 Swedish
Interim / Quarterly Report 2010
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report January 1 – September 30, 2010' and contains comprehensive financial statements, including income statements, balance sheet data, and detailed management commentary on financial performance, business trends, and outlook for the specified nine-month period. It is not a mere announcement or certification, but the full interim financial report itself. 9M 2010
2010-11-12 English
Massachusetts General Hospital i Boston väljer RaySearchs dosplaneringssystem RayStation®
Regulatory Filings Classification · 97% confidence The document is a press release dated October 29, 2010, announcing a specific business event: Massachusetts General Hospital choosing RaySearch's RayStation software. It details a customer win, mentions the financial impact (revenue in Q4, no impact on Q3 results), and provides company background. This type of announcement, focusing on a significant contract or business development that isn't a standard periodic financial report (like 10-K or IR) or a management change (MANG), fits best under the general 'Regulatory Filings' or 'Miscellaneous' category, as it is a formal corporate announcement. Since there is no specific category for 'Customer Wins' or 'Business Updates' other than the general 'RNS' (Regulatory Filings/Miscellaneous announcements), RNS is the most appropriate classification. It is not an Earnings Release (ER) as it only mentions the timing of the Q3 release, nor is it a Call Transcript (CT) or Investor Presentation (IP).
2010-10-29 Swedish
Massachusetts General Hospital in Boston chooses RaySearch’s treatment planning system RayStation®
Regulatory Filings Classification · 97% confidence The document is structured as a 'PRESS RELEASE' dated October 29, 2010, announcing a specific business event: Massachusetts General Hospital selecting RaySearch's RayStation® treatment planning system. It details a contract win, mentions future revenue impact (Q4), and references an upcoming earnings report date ('November 12th'). This type of announcement, focusing on a significant commercial event, partnership, or contract, is typically classified as a general regulatory announcement or news release that doesn't fit the specific financial report categories (like 10-K, ER, IR). Since it is a specific, non-financial-result-focused announcement, and it is not a proxy statement (DEF 14A), director dealing (DIRS), or capital change (CAP), the most appropriate general category for significant, non-standard regulatory news is 'Regulatory Filings' (RNS), which serves as a broad category for important corporate news releases.
2010-10-29 English
Interim / Quarterly Report 2010
Interim / Quarterly Report Classification · 100% confidence The document is a 'Delårsrapport' (Interim Report) for RaySearch Laboratories AB for the period of January 1 to June 30, 2010. It contains comprehensive financial statements, including income statements, balance sheet data, management commentary on business performance, and detailed analysis of revenue and expenses. It is not an announcement of a report, but the report itself, containing substantive financial data. H1 2010
2010-08-27 Swedish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.